https://medicaldialogues.in/news/industry/pharma/innate-pharma-announces-advancement-of-sanofi-developed-nk-cell-engager-sar443579-iph6101-progressing-to-phase-2-for-blood-cancer-patients-127163
Innate Pharma announces advancement of Sanofi-developed NK Cell Engager SAR443579/ IPH6101 progressing to Phase 2 for blood cancer patients